[
  {
    "ts": null,
    "headline": "Charles River Gets Hit By The FDA, Too Early To Bet On A Comeback",
    "summary": "The FDA's new policy to phase out animal testing caused a significant 28% drop in Charles River Labs' stock. Click to read more on why I rate CRL a Sell.",
    "url": "https://finnhub.io/api/news?id=0e3f93344b9e8caf222fcafd204cb6e9e7055f03c6d7e7b3f9132f9986f6aa21",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744445700,
      "headline": "Charles River Gets Hit By The FDA, Too Early To Bet On A Comeback",
      "id": 133894372,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2200850893/image_2200850893.jpg?io=getty-c-w1536",
      "related": "CRL",
      "source": "SeekingAlpha",
      "summary": "The FDA's new policy to phase out animal testing caused a significant 28% drop in Charles River Labs' stock. Click to read more on why I rate CRL a Sell.",
      "url": "https://finnhub.io/api/news?id=0e3f93344b9e8caf222fcafd204cb6e9e7055f03c6d7e7b3f9132f9986f6aa21"
    }
  },
  {
    "ts": null,
    "headline": "What Moved Markets This Week",
    "summary": "What Moved Markets This Week",
    "url": "https://finnhub.io/api/news?id=0ceeb318b0a22f70a575fd49c3ad8de93f041118c297444b0b849c2e7672fe01",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744444210,
      "headline": "What Moved Markets This Week",
      "id": 133894275,
      "image": "",
      "related": "CRL",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=0ceeb318b0a22f70a575fd49c3ad8de93f041118c297444b0b849c2e7672fe01"
    }
  }
]